Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HLA-G promotes immune tolerance.

N Rouas-Freiss1, P Paul, J Dausset

  • 1Service de Recherches en Hemato-Immunologie, CFA-DSV-DRM, Hôpital Saint-Louis, Paris, France.

Journal of Biological Regulators and Homeostatic Agents
|June 7, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Roles of full-length and Δα1 HLA-G isoforms in NK-cell regulation and vascular SARS-CoV-2 infection.

Human immunology·2026
Same author

Cytometry-based analysis of HLA-G functions according to ILT2 expression.

Human immunology·2020
Same author

Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Kidney transplant recipients treated with belatacept exhibit increased naïve and transitional B cells.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

HLA-G 2012 conference: the 15-year milestone update.

Tissue antigens·2013
Same author

Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction.

Leukemia·2012

Human Leukocyte Antigen-G (HLA-G) inhibits immune cell activity, playing a role in pregnancy and cancer. This review covers its immunotolerant functions in materno-fetal tolerance and tumor immunosurveillance.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Human Leukocyte Antigen-G (HLA-G) is a non-classical MHC class I molecule with unique characteristics.
  • It differs from classical HLA molecules through alternative splicing, limited polymorphism, and tissue-restricted expression.
  • Previous studies highlight HLA-G's role in inhibiting NK and T cell-mediated cytolysis.

Purpose of the Study:

  • To review the current understanding of HLA-G's immunotolerant functions.
  • To explore the implications of HLA-G in materno-fetal tolerance.
  • To discuss the role of HLA-G in tumor immunosurveillance.

Main Methods:

  • Review of existing scientific literature on HLA-G.
  • Analysis of studies on HLA-G expression in pregnancy and solid tumors.

Related Experiment Videos

  • Examination of HLA-G's functional impact on immune cells.

    • Main Results:

    • HLA-G isoforms include at least four membrane-bound and two soluble forms.
    • HLA-G expression is observed in solid tumor cells, including melanoma.
    • HLA-G actively inhibits NK and T cell-mediated cytolysis.

    Conclusions:

    • HLA-G possesses significant immunotolerant functions.
    • These functions are critical for maintaining materno-fetal tolerance.
    • HLA-G's role in tumor immunosurveillance presents potential therapeutic implications.